Works matching DE "RENAL cell carcinoma"

Results: 5000

Urothelial Carcinoma Arising on a Functional Kidney Graft.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1118, doi. 10.3390/biomedicines13051118

By:

Moldoveanu, Oana;
Baston, Cătălin;
Sorohan, Bogdan;
Discălicău, Lucas;
Mirvald, Cristian;
Baston, Oana Mădălina;
Sinescu, Ioanel

Publication type:

Article

Natural Compounds in Cancer Therapy: Revealing the Role of Flavonoids in Renal Cell Carcinoma Treatment.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 5, p. 620, doi. 10.3390/biom15050620

By:

Chen, Zixuan;
Liu, Min

Publication type:

Article

Multi-Omics Pan-Cancer Profiling of HSD17B10 Unveils Its Prognostic Potential, Metabolic Regulation, and Immune Microenvironment Interactions.

Published in:

Biology (2079-7737), 2025, v. 14, n. 5, p. 567, doi. 10.3390/biology14050567

By:

Qi, Tao;
Chang, Xiao;
Wang, Yiming

Publication type:

Article

Artesunate Enhances Sensitivity of Renal Cancer Cells to Sunitnib by Mediating Tripartite Motif Containing 24‐Induced Ubiquitination of Paired Box 6.

Published in:

Chemical Biology & Drug Design, 2025, v. 105, n. 5, p. 1, doi. 10.1111/cbdd.70116

By:

Cui, Zelin;
Wen, Jianhua;
Yang, Guanglin;
Wei, Liwei;
Chen, Hao;
Zhao, Qiyue;
Yang, Shubo;
Yu, Jiayin;
Huang, Yichen;
Tan, Shuting;
Mo, Qizhou;
Qin, Min;
Cheng, Jiwen

Publication type:

Article

Prognostic Value of B7-H3 and a Novel Scoring System in Localized Renal Cell Carcinoma.

Published in:

Medicina (1010660X), 2025, v. 61, n. 5, p. 867, doi. 10.3390/medicina61050867

By:

Özalp, Faruk Recep;
Yörükoğlu, Kutsal;
Çalışkan Yıldırım, Eda;
Uzun, Mehmet;
Demirciler, Erkut;
Semiz, Hüseyin Salih

Publication type:

Article

Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.

Published in:

Cellular Oncology (2211-3428), 2025, v. 48, n. 3, p. 775, doi. 10.1007/s13402-025-01048-7

By:

Wang, Jiajun;
Xu, Xianglai;
Wang, Ying;
Zhu, Yanjun

Publication type:

Article

Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study.

Published in:

Cellular Oncology (2211-3428), 2025, v. 48, n. 3, p. 591, doi. 10.1007/s13402-024-01030-9

By:

Yao, Yuntao;
Liu, Yifan;
Lu, Bingnan;
Ji, Guo;
Wang, Lei;
Dong, Keqin;
Zhao, Zihui;
Lyu, Donghao;
Wei, Maodong;
Tu, Siqi;
Lyu, Xukun;
Li, Yuanan;
Huang, Runzhi;
Zhou, Wang;
Xu, Guofeng;
Pan, Xiuwu;
Cui, Xingang

Publication type:

Article

Spontaneous Dramatic Regression of Clear Cell Renal Cell Carcinoma After Pazopanib-Induced Severe Systemic Inflammatory Syndrome: A Case Report and Literature Review.

Published in:

Current Oncology, 2025, v. 32, n. 5, p. 260, doi. 10.3390/curroncol32050260

By:

Oh, Chi Hyuk;
Kim, Hong Jun

Publication type:

Article

Minimally Invasive Surgical Techniques for Renal Cell Carcinoma with Intravenous Tumor Thrombus: A Systematic Review of Laparoscopic and Robotic-Assisted Approaches.

Published in:

Current Oncology, 2025, v. 32, n. 5, p. 256, doi. 10.3390/curroncol32050256

By:

Wu, Yiting;
Feng, Shuyang;
Fu, Ping

Publication type:

Article

Integrative Analysis of Immune- and Metabolism-Related Genes Identifies Robust Prognostic Signature and PYCR1 as a Carcinogenic Regulator in Clear Cell Renal Cell Carcinoma.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4953, doi. 10.3390/ijms26104953

By:

Zhao, Guo;
Ding, Jiatong;
Ma, Jiaxiu;
Jiang, Yale;
Wang, Yuning;
Wang, Shuhang;
Li, Ning

Publication type:

Article

Integrated clinical and proteomic-based model for diagnostic and prognostic prediction in pRCC.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01707-0

By:

Xu, Zeya;
Zhang, Linhui;
Lyu, Jiacheng;
Cai, Maoping;
Ji, Tao;
Bai, Lin;
Li, Liqing;
Zhu, Yao;
Xu, Huashan;
Tan, Subei;
Gan, Hualei;
Ni, Shujuan;
Xu, Wenhao;
Tian, Xi;
Anwaier, Aihetaimujiang;
Liu, Beiyan;
Hou, Qinqin;
Shi, Guohai;
Zhang, Hailiang;
Zhao, Jianyuan

Publication type:

Article

Collision Renal Cell Papillary and Medullary Carcinoma in a 66-Year-Old Man.

Published in:

2013

By:

LAM, ELAINE T.;
KESSLER, ELIZABETH R.;
FLAIG, THOMAS W.;
LA ROSA, FRANCISCO G.

Publication type:

Case Study

Is IL-2 Still Indicated for Melanoma and RCC? What a Question to Ask!

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 695

By:

HAMID, OMID

Publication type:

Article

High-Dose Interleukin-2: Is It Still Indicated for Melanoma and RCC in an Era of Targeted Therapies?

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 680

By:

AMIN, ASIM;
WHITE Jr., RICHARD L.

Publication type:

Article

Weighing the Evidence for Immune Therapy and Targeted Therapy in Renal Cancer and Melanoma.

Published in:

Oncology (08909091), 2013, v. 27, n. 7, p. 691

By:

DORFF, TANYA B.;
WONG, MICHAEL K.

Publication type:

Article

Consultations IN Ethics.

Published in:

Oncology (08909091), 2013, v. 27, n. 4, p. 348

By:

Helft, Paul R.

Publication type:

Article

Targeted Therapy: Its Status and Promise in Selected Solid Tumors Part I: Areas of Major Impact.

Published in:

Oncology (08909091), 2012, v. 26, n. 10, p. 936

By:

Wu, Jennifer;
Joseph, Sasha O.;
Muggia, Franco M.

Publication type:

Article

A Urologic Perspective on Management of Localized and Metastatic RCC.

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 537

By:

JAIN, SAMAY;
ALTER, ROBERT S.;
SAWCZUK, IHOR

Publication type:

Article

Integrating Innovative Therapeutic Strategies Into the Management of Renal Cell Carcinoma.

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 526

By:

DUTCHER, JANICE P.;
FOUAD MOURAD, WALEED;
ENNIS, RONALD D.

Publication type:

Article

Integration of Newer Strategies Into the Management of RCC.

Published in:

Oncology (08909091), 2012, v. 26, n. 6, p. 534

By:

VIRA, MANISH A.

Publication type:

Article

Metastatic RCC: Moving Towards a Chronic Disease.

Published in:

Oncology (08909091), 2012, v. 26, n. 3, p. 304

By:

Escudier, Bernard

Publication type:

Article

Renal Cancer Therapeutics: Now What?

Published in:

Oncology (08909091), 2012, v. 26, n. 3, p. 301

By:

Stadler, Walter M.

Publication type:

Article

Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms.

Published in:

Oncology (08909091), 2012, v. 26, n. 3, p. 290

By:

Posadas, Edwin M.;
Figlin, Robert A.

Publication type:

Article

High-Dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma and Metastatic Melanoma: Still the Standard.

Published in:

2011

By:

DUTCHER, JANICE P.

Publication type:

Opinion

A Young Woman With Multiple Kidney Lesions.

Published in:

Oncology (08909091), 2010, v. 24, n. 3, p. 282

By:

Flaig, Thomas W.;
Kondo, Kimi L.;
La Rosa, Francisco G.;
Kavanagh, Brian;
Crawford, E. David

Publication type:

Article

Pazopanib Approved for Advanced Kidney Cancer.

Published in:: Oncology (08909091), 2009, v. 23, n. 12, p. 1009
Publication type:: Article

Pazopanib Receives Unanimous FDA Panel Approval Recommendation.

Published in:: Oncology (08909091), 2009, v. 23, n. 11, p. 928
Publication type:: Article

Data Show Antitumor Activity With Sunitinib in Patients With Non—Small-Cell Lung Cancer and Irradiated Brain Metastases.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 856
Publication type:: Article

Announcements.

Published in:: Oncology (08909091), 2009, v. 23, n. 7, p. 571
Publication type:: Article

RADOO1 vs Placebo in Patients With Metastatic Renal Cell Carcinoma After Progression on VEGFR-TKI Therapy: Results From a Randomized, Double- Blind, Multicenter Phase Ill Study.

Published in:

2008

By:

Motzer, R. J.;
Escudier, B.;
Oudard, S.

Publication type:

Abstract

Overall Survival With Sunitinib vs Interferon (IFN)-alfa as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC).

Published in:

2008

By:

Figlin, R. A.;
Hutson, T. E.;
Tomczak, P.

Publication type:

Abstract

Genotourinary.

Published in:

Oncology (08909091), 2008, p. 36

By:

Kantoff, Philip;
AppIeman, Leonard J.

Publication type:

Article

Kidney Cancer Patients Treated With Sunitinib Report Lower Severity of Symptoms Compared With Interferon-Alfa.

Published in:: Oncology (08909091), 2008, v. 22, n. 10, p. 1137
Publication type:: Article

Drug Essentials mTOR Inhibitors.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 43

By:

Wilkes, Gail M.

Publication type:

Article

Are We Approaching a Fourth Generation of Therapies for Metastatic Kidney Cancer?

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 402

By:

Vogelzang, Nicholas J.;
Samlowski, Wolfram

Publication type:

Article

Renal Cell Carcinoma: The Fastest Evolving Tumor.

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 396

By:

Escudier, Bernard J.

Publication type:

Article

Targeted Therapy for Metastatic Renal Cell Carcinoma: A Home Run or a Work in Progress?

Published in:

Oncology (08909091), 2008, v. 22, n. 4, p. 388

By:

Rini, Brian I.;
Bukowski, Ronald M.

Publication type:

Article

Temsirolimus Improves Survival in Renal Cell Carcinoma Patients.

Published in:: Oncology (08909091), 2007, v. 21, n. 12, p. 1456
Publication type:: Article

Investigational Drug Cediranib Shows Promise in Patients With Recurrent Glioblastoma.

Published in:: Oncology (08909091), 2007, v. 21, n. 10, p. 1260
Publication type:: Article

Evolving Role of Novel Targeted Agents in Renal Cell Carcinoma.

Published in:

Oncology (08909091), 2007, v. 21, n. 10, p. 1175

By:

Hutson, Thomas E.;
Figlin, Robert A.

Publication type:

Article

A Wealth of Riches in RCC Treatment: How Do We Avoid 'Devaluing the Dollar'?.

Published in:

Oncology (08909091), 2007, v. 21, n. 10, p. 1187

By:

Raghavan, Derek

Publication type:

Article

New Drugs Bring New Questions.

Published in:

Oncology (08909091), 2007, v. 21, n. 10, p. 1184

By:

Quinn, David J.

Publication type:

Article

Sunitinib as Interferon-alfa as First-Line Treatment of Metastatic Renal Cell Carcinoma: Updated Results and Analysis of Prognostic Factors.

Published in:: 2007
Publication type:: Abstract

Phase I/Il Trial of CCI-779 and Bevacizumab in Stage IV Renal Cell Carcinoma: Phase I Safety and Activity Results.

Published in:: 2007
Publication type:: Abstract

Sequential Use of Sorafenib and Sunitinib in Renal Cancer: Retrospective Analysis in 90 Patients.

Published in:: 2007
Publication type:: Abstract

A Phase II Trial of lntra-Patient Dose-Escalated Sorafenib in Patients With Metastatic Renal Cell Cancer.

Published in:: 2007
Publication type:: Abstract

Exposure-Response of Sunitinib in Metastatic Renal Cell Carcinoma: A Population Pharmacokinetic/ Pharmacodynamic Approach.

Published in:: 2007
Publication type:: Abstract

Randomized Phase II Trial of First-Line Treatment With Sorafenib as Interferon in Patients With Advanced Renal Cell Carcinoma: Final Results.

Published in:: 2007
Publication type:: Abstract

A Randomized, Controlled, Double- Blind Phase Ill Study (AVOREN) of Bevacizumob/lnterferon-α2a as Placebo! lnterferon-α2a as First-Line Therapy in Metastatic Renal Cell Carcinoma.

Published in:: 2007
Publication type:: Abstract

ASCO 2007: Plenary Top 5.

Published in:: 2007
Publication type:: Conference Paper/Materials